Status: Recruiting
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.
Participants needed: 210
Trial details
Phase: Phase 4Age: 6-24Biological sex: AllType: InterventionalSponsor: University of OuluUpdated: Feb 13, 2025Locations: 2
Eligibility criteria
Wheezing bronchitis diagnosed by a physician [+2]
Need for immediate resuscitation [+14]